Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jan 27;55(1):1-11.
doi: 10.1515/helm-2017-0048. eCollection 2018 Mar.

Helminth Therapy: Advances in the use of Parasitic Worms Against Inflammatory Bowel Diseases and its Challenges

M Maruszewska-Cheruiyot  1 , K Donskow-Łysoniewska  1 , M Doligalska  1
Affiliations

Helminth Therapy: Advances in the use of Parasitic Worms Against Inflammatory Bowel Diseases and its Challenges

M Maruszewska-Cheruiyot et al. Helminthologia. .

Abstract

Development of modern medicine and better living conditions in the 20th century helped in reducing a number of cases of infectious diseases. During the same time, expansion of autoimmunological disorders was noticed. Among other are Inflammatory Bowel Diseases (IBD) including ulcerative colitis and Crohn's disease which are chronic and relapsing inflammation of the gastrointestinal tract. Absence of effective treatment in standard therapies effects the search for alternative opportunities. As per hygienic hypothesis increasing number of cases of autoimmune diseases is as a result of reduced exposure to pathogens, especially parasites. Thus, one of the promising remedial acts against IBD and other allergic and autoimmune disorders is "helminth therapy". Cure with helminths seems to be the most effective therapy of IBD currently proposed. Helminth therapy focuses on advantageous results that have been obtained from the clinical trials, but its mechanisms are still unclear. Explanation of this phenomenon would help to develop new drugs against IBD based on helminth immunomodulatory molecules.

Keywords: Heligmosomoides polygyrus; Inflammatory Bowel Diseases; helminth therapy; ulcerative colitis.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. ADISAKWATTANA P., NUAMTANONG S., KUSOLSUK T., CHAIROJ M., YENCHITSOMANAS P.T., CHAISRI U.. Non-encapsulated Trichinella spp., T. papuae diminishes severity of DSS-induced colitis in mice. Asian Pac. J. Allergy Immunol. 2013;31:106–114. doi: 10.12932/AP0238.31.2.2013. - DOI - PubMed
    1. ALLEN J.E., MAIZELS R.M.. Diversity and dialogue in immunity to helminths. Nat. Rev. Immunol. 2011;11:375–388. doi: 10.1038/nri2992. - DOI - PubMed
    1. BARTHLOTT T., KASSIOTIS G., STOCKINGER B.. T cell regulation as a side effect of homeostasis and competition. J. Exp. Med. 2003;197:451–460. doi: 10.1084/jem.20021387. - DOI - PMC - PubMed
    1. BERNSTEIN R.M.. Injections and surgical therapy in chronic pain. Clin. J. Pain. 2001;17:94–104. - PubMed
    1. BIEDERMANN L., ZEITZ J., MWINYI J., SUTTER-MINDER E., REHMAN A., OTT S. J., STEURER-STEY C., FREI A., FREI P., SCHARL M., LOESSNER M. J., VAVRICKA S. R., FRIED M., SCHREIBER S., SCHUPPLER M., ROGLER G.. Smoking cessation induces profound changes in the composition of the intestinal microbiota in humans. PLoS One. 2013;8:e59260. doi: 10.1371/journal.pone.0059260. - DOI - PMC - PubMed

LinkOut - more resources